Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders

Kravitz, 2008, Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women, Sleep., 31, 979 Heinzer, 2018, Impact of sex and menopausal status on the prevalence, clinical presentation, and comorbidities of sleep-disordered breathing, Sleep Med., 51, 29, 10.1016/j.sleep.2018.04.016 Manconi, 2012, When gender matters: restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS study group, Sleep Med. Rev., 16, 297, 10.1016/j.smrv.2011.08.006 Armeni, 2016, Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS), Maturitas, 89, 63, 10.1016/j.maturitas.2016.04.013 2015 Erlik, 1981, Association of waking episodes with menopausal hot flushes, JAMA J. Am. Med. Assoc., 245, 1741, 10.1001/jama.1981.03310420031025 Attarian, 2015, Treatment of chronic insomnia disorder in menopause: evaluation of literature, Menopause., 22, 674, 10.1097/GME.0000000000000348 Tansupswatdikul, 2015, Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: A randomized trial, Climacteric, 18, 198, 10.3109/13697137.2014.964670 Utian, 2009, Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women, Maturitas, 63, 329, 10.1016/j.maturitas.2009.06.006 Pinkerton, 2014, Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial, Menopause, 21, 252, 10.1097/GME.0b013e31829f0433 Maki, 2019, Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations, J. Womens Health (Larchmt), 28, 117, 10.1089/jwh.2018.27099.mensocrec Handley, 2015, The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review, J. Am. Assoc. Nurse Pract., 27, 54, 10.1002/2327-6924.12137 Ensrud, 2015, Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes, Sleep, 38, 97, 10.5665/sleep.4332 Freeman, 2011, Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial, JAMA - J. Am. Med. Assoc., 305, 267, 10.1001/jama.2010.2016 Mansikkamäki, 2012, Sleep quality and aerobic training among menopausal women - A randomized controlled trial, Maturitas., 72, 339, 10.1016/j.maturitas.2012.05.003 Baker, 2015, Insomnia in women approaching menopause: beyond perception, Psychoneuroendocrinology., 60, 96, 10.1016/j.psyneuen.2015.06.005 Baker, 2018, Sleep problems during the menopausal transition: Prevalence, impact, and management challenges, Nat. Sci. Sleep, 10, 73, 10.2147/NSS.S125807 Blümel, 2012, A multinational study of sleep disorders during female mid-life, Maturitas., 72, 359, 10.1016/j.maturitas.2012.05.011 Xu, 2014, Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis, Menopause, 21, 1301, 10.1097/GME.0000000000000240 Dorsey, 2004, Effect of Zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: A 4-week, randomized, multicenter, double-blind, placebo-controlled study, Clin. Ther., 26, 1578, 10.1016/j.clinthera.2004.10.003 Soares, 2006, Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial, Obstet. Gynecol., 108, 1402, 10.1097/01.AOG.0000245449.97365.97 Joffe, 2010, Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial, Am. J. Obstet. Gynecol., 202, 171.e1, 10.1016/j.ajog.2009.10.868 Dobkin, 2009, Ramelteon for the treatment of insomnia in menopausal women, Menopause Int., 15, 13, 10.1258/mi.2009.009002 Pinkerton, 2015, Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause, Menopause., 22, 50, 10.1097/GME.0000000000000311 Dolev, 2011, Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy, Arch. Womens Ment. Health, 14, 269, 10.1007/s00737-011-0205-7 Suvanto-Luukkonen, 2005, Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study, Menopause., 12, 18, 10.1097/00042192-200512010-00006 Soares, 2006, Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life, Menopause, 13, 780, 10.1097/01.gme.0000240633.46300.fa DeFronzo, 2009, Escitalopram reduces hot flashes in nondepressed menopausal women: a pilot study, Ann. Clin. Psychiatry, 21, 70 Ensrud, 2012, Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial, Menopause., 19, 848, 10.1097/gme.0b013e3182476099 Davari-Tanha, 2016, Comparison of citalopram and venlafaxine’s role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial, Arch. Gynecol. Obstet., 293, 1007, 10.1007/s00404-015-3900-1 Joffe, 2014, Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial, JAMA Intern. Med., 174, 1058, 10.1001/jamainternmed.2014.1891 Guthrie, 2018, Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and self-reported sleep quality in women with hot flashes: a pooled analysis of individual participant data from four MsFLASH trials, Sleep, 41 Cohen, 2014, Efficacy of omega-3 for vasomotor symptoms treatment: A randomized controlled trial, Menopause, 21, 347, 10.1097/GME.0b013e31829e40b8 Taavoni, 2011, Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial, Menopause, 18, 951, 10.1097/gme.0b013e31820e9acf Federici, 2016, Hypothalamic orexin’s role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model, Psychoneuroendocrinology, 65, 127, 10.1016/j.psyneuen.2015.12.011 Cintron, 2017, Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy, Maturitas, 99, 59, 10.1016/j.maturitas.2017.01.016 Trauer, 2015, Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis, Ann. Intern. Med., 163, 191, 10.7326/M14-2841 Fu, 2017, Acupuncture improves peri-menopausal insomnia: a randomized controlled trial, Sleep, 40, 11, 10.1093/sleep/zsx153 Riemann, 2017, European guideline for the diagnosis and treatment of insomnia, J. Sleep Res., 26, 675, 10.1111/jsr.12594 McCurry, 2016, Telephone-Based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms A MsFLASH randomized clinical trial, JAMA Intern. Med., 176, 913, 10.1001/jamainternmed.2016.1795 Drake, 2019, Treating chronic insomnia in postmenopausal women: A randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education, Sleep., 42, 10.1093/sleep/zsy217 Walters, 2005, Effect of menopause on melatonin and alertness rhythms investigated in constant routine conditions, Chronobiol. Int., 22, 859, 10.1080/07420520500263193 Okatani, 2000, Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations, J. Pineal Res., 28, 111, 10.1034/j.1600-079X.2001.280207.x Gómez-Santos, 2016, Menopause status is associated with circadian- and sleep-related alterations, Menopause, 23, 682, 10.1097/GME.0000000000000612 Toffol, 2014, Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life, Menopause, 21, 493, 10.1097/GME.0b013e3182a6c8f3 Parry, 2006, Sleep, rhythms and women’s mood. Part II. Menopause, Sleep Med. Rev., 10, 197, 10.1016/j.smrv.2005.09.004 Gursoy, 2015, Melatonin in aging women, Climacteric, 18, 790, 10.3109/13697137.2015.1052393 Lévy, 2015, Obstructive sleep apnoea syndrome, Nat. Rev. Dis. Primers, 25, 15015, 10.1038/nrdp.2015.15 Campos-Rodriguez, 2017, Spanish Sleep Network. Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea, Eur. Respir. J., 50 Rietz, 2018, Nocturnal blood pressure is reduced by a mandibular advancement device for sleep apnea in women: findings from secondary analyses of a randomized trial, J. Am. Heart Assoc., 7, 10.1161/JAHA.118.008642 Kritikou, 2016, Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure, Eur. Respir. J., 47, 531, 10.1183/13993003.00319-2015 Jennum, 2015, All-cause mortality from obstructive sleep apnea in male and female patients with and without continuous positive airway pressure treatment: a registry study with 10 years of follow-up, Nat. Sci. Sleep, 7, 43, 10.2147/NSS.S75166 Anttalainen, 2014, Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study, Menopause., 21, 361, 10.1097/GME.0000000000000130 Kryger, 2017 Ghorayeb, 2008, Perceived severity of restless legs syndrome across the female life cycle, Sleep Med., 9, 799, 10.1016/j.sleep.2007.07.018 Fabbrini, 2015, Sleep disorders in menopause: results from an Italian multicentric study, Arch. Ital. Biol., 153 Hachul, 2009, Sleep in post-menopausal women: differences between early and late post-menopause, Eur. J. Obstet. Gynecol. Reprod. Biol., 145, 81, 10.1016/j.ejogrb.2009.03.019 Hachul, 2010, Does the reproductive cycle influence sleep patterns in women with sleep complaints?, Climacteric., 13, 594, 10.3109/13697130903450147 Bagheri, 2018, The prevalence of restless legs syndrome and its relationship with demographic characteristics and medical disorders in postmenopausal Iranian women, Health Care Women Int., 1 Wesström, 2008, Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause, Climacteric, 11, 422, 10.1080/13697130802359683 Wesström, 2014, Periodic limb movements are associated with vasomotor symptoms, J. Clin. Sleep Med., 10, 15, 10.5664/jcsm.3348 Montplaisir, 2000, Pramipexole in the treatment of restless legs syndrome: a follow-up study, Eur. J. Neurol., 27, 10.1046/j.1468-1331.2000.0070s1027.x Polo-Kantola, 2001, Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial, Obstet. Gynecol., 97, 548 Montplaisir, 2001, Sleep in menopause: differential effects of two forms of hormone replacement therapy, Menopause., 8, 10, 10.1097/00042192-200101000-00004 Eichling, 2005, Menopause related sleep disorders, J. Clin. Sleep Med., 1, 291, 10.5664/jcsm.26347 Hachul, 2007, Estrogen therapy reduces nocturnal periodic limb movements, Maturitas., 58, 319, 10.1016/j.maturitas.2007.08.009 Hachul, 2008, Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women, Int. J. Gynecol. Obstet., 103, 207, 10.1016/j.ijgo.2008.07.009 Innes, 2012, The effects of a gentle yoga program on sleep, mood, and blood pressure in older women with restless legs syndrome (RLS): a preliminary randomized controlled trial, Evidence-Based Complement, Altern. Med., 2012 Innes, 2013, Efficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study, J. Altern. Complement. Med., 19, 527, 10.1089/acm.2012.0330